1.
Zou T, Zhou M, Gupta A, et al. XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells. Cell reports. 2024;43(2):113600. doi:10.1016/j.celrep.2023.113600.
1.
Windred DP, Burns AC, Lane JM, et al. Sleep regularity is a stronger predictor of mortality risk than sleep duration: A prospective cohort study. Sleep. 2024;47(1). doi:10.1093/sleep/zsad253.
1.
Salahudeen AA, Seoane JA, Yuki K, et al. Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis. Cell reports. 2023;42(11):113355. doi:10.1016/j.celrep.2023.113355.
1.
Sahgal P, Patil DT, Bala P, et al. Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. iScience. 2023;26(11):108169. doi:10.1016/j.isci.2023.108169.
1.
Oren O, Natarajan P, Bhatt DL. SGLT2 Inhibitors in Patients With Cancer Therapy-Related Cardiotoxicity: An Unexpected Benefit?. JACC. Heart failure. 2024;12(1):79-82. doi:10.1016/j.jchf.2023.10.005.
1.
Ghislanzoni S, Kang JW, Bresci A, et al. Optical Diffraction Tomography and Raman Confocal Microscopy for the Investigation of Vacuoles Associated with Cancer Senescent Engulfing Cells. Biosensors. 2023;13(11). doi:10.3390/bios13110973.
1.
Kaczanowska S, Murty T, Alimadadi A, et al. Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy. Cancer cell. 2024;42(1):35-51.e8. doi:10.1016/j.ccell.2023.11.011.
1.
Hofman DA, Ruiz-Orera J, Yannuzzi I, et al. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Molecular cell. 2024;84(2):261-276.e18. doi:10.1016/j.molcel.2023.12.003.
1.
Iorgulescu B, Ruthen N, Ahn R, et al. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Frontiers in immunology. 2023;14:1297932. doi:10.3389/fimmu.2023.1297932.
1.
Dufva O, Gandolfi S, Huuhtanen J, et al. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers. Immunity. 2023;56(12):2816-2835.e13. doi:10.1016/j.immuni.2023.11.008.